- Active ingredient (in each 3 mini-tablet dose)
- Purpose
- Uses
- Warnings
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
-
Principal Display Panel
NEW!
CONVENIENT POCKET PACK
Mylanta®
GAS Minis
- ▪
- Fast relief of the bloating , pressure, and discomfort of gas
- ▪
- Extra Strength, with the #1 selling medicine for gas relief
- ▪
- Great tasting ,chewable mini-tablets in an on-the-go pack
- ▪
- Also available in great tasting Arctic Mint & Assorted Fruit
TAMPER EVIDENT: DO NOT USE MYLANTA GAS MINI-TABLETS IF THE BREAKAWAY BAND ON TOP OF CONTAINER IS BROKEN OR MISSING.
-
Mylanta is a registered trademark of McNeil Consumer Pharmaceuticals Co.
Patent pending
infirst+
HEALTHCARE
Manufactured for:
Infirst Healthcare Inc.
Westport, CT 06880
©2016 Infirst Healthcare Inc.
Mylanta.com
KEEP OUTER PACKAGING FOR COMPLETE LABELING
K PARVE
-
INGREDIENTS AND APPEARANCE
MYLANTA GAS MINIS CHERRY FLAVOR
simethicone tablet, chewableProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:62372-802 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O) DIMETHICONE 125 mg Inactive Ingredients Ingredient Name Strength ADIPIC ACID (UNII: 76A0JE0FKJ) CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM (UNII: K679OBS311) HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P) ISOMALT (UNII: S870P55O2W) MAGNESIUM STEARATE (UNII: 70097M6I30) MALTODEXTRIN (UNII: 7CVR7L4A2D) D&C RED NO. 27 (UNII: 2LRS185U6K) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) SUCRALOSE (UNII: 96K6UQ3ZD4) SUCROSE (UNII: C151H8M554) TRICALCIUM PHOSPHATE (UNII: K4C08XP666) Product Characteristics Color PINK (LIGHT PINK) Score no score Shape OVAL (OBLONG) Size 12mm Flavor CHERRY Imprint Code MYLG Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:62372-802-50 50 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 08/05/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part332 08/05/2019 Labeler - Infirst Healthcare Inc. (079159739)